Tag Archives: Alzheimer's disease

435 New Medicines in Development for “Older Americans”

By Melanie Sena. According to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA), America’s biopharmaceutical research companies are developing 435 new medicines to target 15 leading chronic conditions affecting the Medicare population. These medicines in development include: 110 for diabetes, 62 for rheumatoid arthritis and osteoarthritis, 67 for Alzheimer’s disease, 61 […]
Posted in healthcare, R&D | Also tagged , , , , | Leave a comment

Adaptive Trial Design and Combo Drugs Needed in Alzheimer’s

FDA’s head of neurology products told industry execs at the Prix Galien Forum that the agency is open to alternative clinical trial designs in Alzheimer’s disease, and would like to see more combination products in clinical testing.
Posted in Agency Insight, FDA, R&D, Regulatory | Also tagged , , | Leave a comment

Alzheimer’s Test Offers Early Diagnosis

Image via Wikipedia A research team in Belgium discovered a new test that has proven successful at identifying patients that are developing Alzheimer’s disease, according to a report published in the Archives of Neurology on Tuesday. The study took spinal fluid from patients with varying levels of cognitive memory and looked for a specific protein […]
Posted in R&D, Technology | Also tagged , , , , , , , | Leave a comment

NICE Stats Spur Controversy and Back Patting

The UK’s National Health Service has released its first statistics that show how NICE approval has affected medicines uptake in the UK. The NHS Information Centre’s Metrics Working Group looked at 26 medicines that the NICE has said should be reimbursed and how they were prescribed in 2008. It then compared the actual usage with […]
Posted in Strategy | Also tagged , , , , , , , | Leave a comment
  • Categories

  • Meta